Back to AQR CAPITAL MANAGEMENT LLC

REGN
Showing 8 of 30 quarters

Position history for AQR CAPITAL MANAGEMENT LLC's holdings in REGENERON PHARMACEUTICALS

AQR CAPITAL MANAGEMENT LLC holds 1.2M shares of REGN (REGENERON PHARMACEUTICALS), worth $946M as of 2026-Q1. The position was increased (+23.6% shares). REGN represents 0.4% of AQR CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$946M

Current Shares

1.2M

Total Value Change

+$747.4M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.2M
+23.6%
$946M0.4%$766.66
46
2025-Q4
Increased
995,710
+38.0%
$768.5M0.4%$773.94
50
2025-Q3
Increased
721,354
+528.7%
$405.6M0.3%$560.05
60
2025-Q2
Decreased
114,742
-51.4%
$59.7M0.0%$519.56
0
2025-Q1
Increased
235,950
+13.9%
$148.7M0.2%$634.66
41
2024-Q4
Decreased
207,085
-8.2%
$147.1M0.2%$698.71
0
2024-Q3
Increased
225,534
+19.1%
$235.2M0.3%$1,036.94
43
2024-Q2
Increased
189,291
+3.8%
$198.6M0.3%$1,045.23
38

Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used